FMS (Fresenius Medical Care AG) יחס שווי שוק לשווי בספרים

The battle for market share within a duopoly and the pressure from biotech innovations are impacting the P/BV ratio history for Fresenius Medical Care (FMS). A steady profit stream from chronic patients supports the share price, although staffing shortages in the US are creating costs. The 0.84 indicator determines the metric's magnitude, revealing the trade-off between asset reliability and the potential for yield growth under listing rules.

This ratio compares the market value of Fresenius Medical Care (FMS) to its net assets, making it possible to determine the degree of business overvaluation or the proximity of the price to critical support levels. By analyzing the market capitalization valuation trend relative to the balance sheet, an investor can assess the company's resilience to changes in government dialysis tariffs and rising operational personnel costs.